Agios Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD 5.72B 1.98B 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amgen USD 2.66B 1.37B 2025-06
Arrowhead Research USD -165550000 546.75M 2025-06
Astellas Pharma JPY 92.54B 29.02B 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Bayer EUR 13M 2.31B 2025-06
Biogen USD 851.8M 540.6M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Daiichi Sankyo JPY 96.71B 13.1B 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Exelixis USD 215.68M 28.82M 2025-07
Gilead Sciences USD 2.7B 467M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
Incyte USD 310.82M 105.66M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Merck USD 6.36B 494M 2025-06
Moderna USD -907000000 143M 2025-06
Novartis USD 4.86B 201M 2025-06
Novartis USD 3.4B 193M 2024-12
Pfizer USD 2.6B 1.06B 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06


Agios Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.